A novel RyR2 mutation in a 2-year-old baby presenting with atrial fibrillation, atrial flutter, and atrial ectopic tachycardia

Heart Rhythm

Volumn 11, Issue 8, 2014, Pages 1480-1483

  Di Pino, Alfredo ^a   Caruso, Elio ^a   Costanzo, Luca ^a,b   Guccione, Paolo ^a  

^a San Vincenzo Hospital   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Atrial arrhythmia; Catecholaminergic ventricular tachycardia; Genetic mutation; Pediatric tachyarrhythmia; Ryanodine receptor 2

Indexed keywords

AMIODARONE; ATENOLOL; DNA; FLECAINIDE; NADOLOL; PROPRANOLOL; RYANODINE RECEPTOR 2; RYANODINE RECEPTOR;

AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHILD; CONTINUOUS INFUSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ECTOPIC ATRIAL TACHYCARDIA; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; GENE IDENTIFICATION; GENE MUTATION; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITORING; HUMAN; OPEN READING FRAME; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SCHOOL CHILD; SINUS BRADYCARDIA; THYROID DISEASE; TREADMILL EXERCISE; COMPLICATION; ELECTROCARDIOGRAPHY; GENETICS; METABOLISM; MUTATION; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

ATRIAL FIBRILLATION; ATRIAL FLUTTER; CHILD, PRESCHOOL; DNA; DNA MUTATIONAL ANALYSIS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MUTATION; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TACHYCARDIA, ECTOPIC ATRIAL;

EID: 84905028248     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.04.037     Document Type: Article

References (16)

1. A. Leenhardt, V. Lucet, I. Denjoy, F. Grau, D.D. Ngoc, and P. Coumel Catecholaminergic polymorphic ventricular tachycardia in children Circulation 91 1995 1512 1519
2. S.G. Priori, C. Napolitano, N. Tiso, M. Memmi, G. Vignati, R. Bloise, V. Sorrentino, and G.A. Danieli Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia Circulation 103 2001 196 200
3. S.G. Priori, C. Napolitano, and M. Memmi et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia Circulation 106 2002 69 74
4. N. Sumitomo, H. Sakurada, and K. Taniguchi et al. Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia Circ J 71 2007 1606 1609
5. A. Metha, G.R. Sanchez, E.J. Sacks, A. Casta, J.M. Dunn, and R.M. Donner Ectopic Automatic Atrial tachycardia in children: clinical characteristics, management and follow-up J Am Call Cardiol 11 1988 379 385
6. N. Liu, M. Denegri, Y. Ruan, J.E. Avelino-Cruz, A. Perissi, S. Negri, C. Napolitano, W.A. Coetzee, P.A. Boyden, and S.G. Priori Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity Circ Res 109 2011 291 295
7. 2+ spark mass J Mol Cell Cardiol 48 2010 293 301
8. 2+) spark and wave frequency via inhibition of the sarcolemmal sodium current Cardiovasc Res 98 2013 286 296
9. M. Faggioni, E. Savio-Galimberti, R. Venkataraman, H.S. Hwang, P.J. Kannankeril, D. Darbar, and B.C. Knollmann Suppression of spontaneous Ca elevations prevents atrial fibrillation in Casq2 null hearts Circ Arrhythm Electrophysiol 7 2014 313 320
10. C. van der Werf, P.J. Kannankeril, and F. Sacher et al. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia J Am Coll Cardiol 57 2011 2244 2254
11. J.A. Vest, X.H. Wehrens, S.R. Reiken, S.E. Lehnart, D. Dobrev, P. Chandra, P. Danilo, U. Ravens, M.R. Rosen, and A.R. Marks Defective cardiac ryanodine receptor regulation during atrial fibrillation Circulation 111 2005 2025 2032
12. Y. Zhang, G.D. Matthews, M. Lei, and C.L. Huang Abnormal Ca2+ homeostasis, atrial arrhythmogenesis, and sinus node dysfunction in murine hearts modeling RyR2 modification Front Physiol 4 2013 150
13. A. Medeiros-Domingo, Z.A. Bhuiyan, D.J. Tester, D.J. Tester, N. Hofman, H. Bikker, J.P. van Tintelen, M.M. Mannens, A.A. Wilde, and M.J. Ackerman The RYR2-Encoded Ryanodine Receptor/Calcium Release Channel in Patients Diagnosed Previously With Either Catecholaminergic Polymorphic Ventricular Tachycardia or Genotype Negative, Exercise-Induced Long QT Syndrome: A Comprehensive Open Reading Frame Mutational Analysis J Am Coll Cardiol 54 2009 2065 2074
14. P.J. Laitinen, K.M. Brown, and K. Piippo et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia Circulation 103 2001 485 490
15. P. Kazemian, M.H. Gollob, A. Pantano, and G.Y. Oudit A novel mutation in the RYR2 gene leading to catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation: dose-dependent arrhythmia-event suppression by -blocker therapy Can J Cardiol 27 2011 870 e7-10
16. S. Pizzale, M.H. Gollob, R. Gow, and D.H. Birnie Sudden death in a young man with catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation J Cardiovasc Electrophysiol 19 2008 1319 1321